ENDS Report 444, January 2012, pp. 42-43
23 January 2012
Arguments over the latest group of chemicals slated for authorisation under REACH highlight wider aspects of the European Chemicals Agency’s approach.
The full text of this article is only available to current registered subscribers and free trialists.
Subscribe for full access
or Sign up for a free trial subscription.
Already subscribe but don't have a password?
Activate your web account here.
